Market Research Logo

Genomic Health Inc (GHDX) - Product Pipeline Analysis, 2018 Update

Summary

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genomic Health Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Genomic Health Inc Company Overview
Genomic Health Inc Company Snapshot
Genomic Health Inc Pipeline Products and Ongoing Clinical Trials Overview
Genomic Health Inc – Pipeline Analysis Overview
Business Description
Genomic Health Inc - Key Facts
Genomic Health Inc - Major Products and Services
Genomic Health Inc Pipeline Products by Development Stage
Genomic Health Inc Pipeline Products Overview
Diagnostic Test - Non Small Cell Lung Cancer
Diagnostic Test - Non Small Cell Lung Cancer Product Overview
Liquid Biopsy-Based Bladder Cancer Test
Liquid Biopsy-Based Bladder Cancer Test Product Overview
Negative Biopsy Test - Prostate Cancer
Negative Biopsy Test - Prostate Cancer Product Overview
Next Generation Sequencing Oncotype DX - Prostate Cancer Assay
Next Generation Sequencing Oncotype DX - Prostate Cancer Assay Product Overview
Oncotype Dx - Kidney Cancer
Oncotype Dx - Kidney Cancer Product Overview
Oncotype Dx Colon Cancer Assay - Oxaliplatin
Oncotype Dx Colon Cancer Assay - Oxaliplatin Product Overview
Oncotype DX IVD Test
Oncotype DX IVD Test Product Overview
Oncotype SEQ - Breast Cancer Test
Oncotype SEQ - Breast Cancer Test Product Overview
Oncotype SEQ - Tissue Mutation Panel
Oncotype SEQ - Tissue Mutation Panel Product Overview
Oncotype TRACK
Oncotype TRACK Product Overview
Prognostic Test - Melanoma
Prognostic Test - Melanoma Product Overview
Prognostic Test - Non-Metastatic Renal Cell Carcinoma
Prognostic Test - Non-Metastatic Renal Cell Carcinoma Product Overview
Genomic Health Inc - Key Competitors
Genomic Health Inc - Key Employees
Genomic Health Inc - Key Employee Biographies
Genomic Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Genomic Health Inc, Recent Developments
May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results
Apr 26, 2018: Large Independent Study Using the Oncotype DX Test Accepted for Presentation at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Mar 23, 2018: New Real-World Clinical Practice Data Reinforces the Value of the Oncotype DX Breast Recurrence Score Test for Patients, Physicians and the Health Care System
Mar 15, 2018: Landmark TAILORx Results Aid in Assessing the Effect of Chemotherapy in Women with Early-stage Breast Cancer and Oncotype DX Breast Recurrence Score Results of 11 to 25
Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook
Feb 26, 2018: Cesca Therapeutics Announces Commercial Launch Of AXP II System For Advanced Cord Blood Processing
Feb 26, 2018: Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX AR-V7 Nucleus Detect Test to Predict Treatment Response in Metastatic Disease
Feb 15, 2018: First comparison of common breast cancer tests finds varied accuracy of predictions
Feb 05, 2018: Oncotype DX Genomic Prostate Score Test Increases Use of Active Surveillance by 30 Percent in Low-risk Patients, Resulting in Greater Adherence to Guideline-based Care
Jan 08, 2018: Gene Test to Predict Breast Cancer Recurrence Less Cost Effective in Real World Practice
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genomic Health Inc Pipeline Products and Ongoing Clinical Trials Overview
Genomic Health Inc Pipeline Products by Equipment Type
Genomic Health Inc Pipeline Products by Indication
Genomic Health Inc, Key Facts
Genomic Health Inc, Major Products and Services
Genomic Health Inc Number of Pipeline Products by Development Stage
Genomic Health Inc Pipeline Products Summary by Development Stage
Diagnostic Test - Non Small Cell Lung Cancer - Product Status
Diagnostic Test - Non Small Cell Lung Cancer - Product Description
Liquid Biopsy-Based Bladder Cancer Test - Product Status
Liquid Biopsy-Based Bladder Cancer Test - Product Description
Negative Biopsy Test - Prostate Cancer - Product Status
Negative Biopsy Test - Prostate Cancer - Product Description
Next Generation Sequencing Oncotype DX - Prostate Cancer Assay - Product Status
Next Generation Sequencing Oncotype DX - Prostate Cancer Assay - Product Description
Oncotype Dx - Kidney Cancer - Product Status
Oncotype Dx - Kidney Cancer - Product Description
Oncotype Dx Colon Cancer Assay - Oxaliplatin - Product Status
Oncotype Dx Colon Cancer Assay - Oxaliplatin - Product Description
Oncotype DX IVD Test - Product Status
Oncotype DX IVD Test - Product Description
Oncotype SEQ - Breast Cancer Test - Product Status
Oncotype SEQ - Breast Cancer Test - Product Description
Oncotype SEQ - Tissue Mutation Panel - Product Status
Oncotype SEQ - Tissue Mutation Panel - Product Description
Oncotype TRACK - Product Status
Oncotype TRACK - Product Description
Prognostic Test - Melanoma - Product Status
Prognostic Test - Melanoma - Product Description
Prognostic Test - Non-Metastatic Renal Cell Carcinoma - Product Status
Prognostic Test - Non-Metastatic Renal Cell Carcinoma - Product Description
Genomic Health Inc, Key Employees
Genomic Health Inc, Key Employee Biographies
Genomic Health Inc, Other Locations
Genomic Health Inc, Subsidiaries
Glossary
List of Figures
Genomic Health Inc Pipeline Products by Equipment Type
Genomic Health Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report